Jager Pharma Advisory Private Limited
Provides pharmaceutical marketing and consulting services for various healthcare products and technologies.
2020 | Mumbai, Maharashtra (India) | Active
Jager Pharma Advisory Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 30.55%
- Profit Growth 26.03%
- Ebitda 24.57%
- Net Worth 124.34%
- Total Assets 116.43%
About Jager Pharma Advisory
Jager Pharma Advisory Private Limited (JPAPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 January 2020 (Five years and one month 15 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaswinder Gill and Nikhila Singh serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2020PTC335883
- Company No.
335883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Business Outsourcing
Who are the key members and board of directors at Jager Pharma Advisory?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaswinder Gill  | Managing Director | 13-Jan-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhila Singh | Director | 13-Jan-2020 | Current |
Financial Performance of Jager Pharma Advisory.
Jager Pharma Advisory Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.55% increase. The company also saw a substantial improvement in profitability, with a 26.03% increase in profit. The company's net worth Soared by an impressive increase of 124.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jager Pharma Advisory?
Unlock access to Jager Pharma Advisory's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jager Pharma Advisory?
Unlock and access historical data on people associated with Jager Pharma Advisory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jager Pharma Advisory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jager Pharma Advisory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Jager Pharma Advisory
Recent activity within the organization
- Annual General Meeting
Jager Pharma Advisory Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
30 Sep 2024
- Balance Sheet
Jager Pharma Advisory Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
31 Mar 2024
- Director Appointment
Jaswinder Gill was appointed as a Managing Director was appointed as a Managing Director on 13 Jan 2020 & has been associated with this company since 5 years 1 month .
13 Jan 2020
- Director Appointment
Nikhila Singh was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 5 years 1 month .
13 Jan 2020
- Company Incorporation
Jager Pharma Advisory Private Limited was registered on 13 Jan 2020 with Roc Mumbai & aged 5 years 1 month as per MCA records.
13 Jan 2020
Frequently asked questions
What is the Incorporation or founding date of Jager Pharma Advisory Private Limited?
Jager Pharma Advisory Private Limited was incorporated on 13 Jan 2020.
What is authorized share capital and paid-up capital of Jager Pharma Advisory Private Limited?
The authorized share capital of Jager Pharma Advisory Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Jager Pharma Advisory Private Limited?
Currently 2 directors are associated with Jager Pharma Advisory Private Limited.
- Jaswinder Gill
- Nikhila Singh
What is the registered address of Jager Pharma Advisory Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Jager Pharma Advisory Private Limited is 13-4A Kalpataru Estate Jvl Road Andheri East India, Mumbai, Maharashtra, 400093.
What is the corporate identification number (CIN) and company number of Jager Pharma Advisory Private Limited?
The corporate identification number (CIN) of Jager Pharma Advisory Private Limited is U74999MH2020PTC335883 and the company number is 335883 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Jager Pharma Advisory Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Jager Pharma Advisory Private Limited has risen by 30.55%.
What change has been observed in the net worth of Jager Pharma Advisory Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Jager Pharma Advisory Private Limited has experienced an upsurge of 124.34%.
When was the last Balance Sheet of Jager Pharma Advisory Private Limited filed with the ROC?
The most recent Balance Sheet for Jager Pharma Advisory Private Limited was filed with the ROC on 31 Mar 2024.